SBI completes Rs 2.97 crore CareEdge Global stake purchase
Key highlights
- SBI completed the purchase of 29,70,000 CareEdge Global shares on 16 November 2026.
- The Rs 2.97 crore cash investment gives SBI a 9.90% holding in CareEdge Global.
- CareEdge Global’s FY26 turnover was Rs 9.0029 crore, compared with Rs 1.9524 crore in FY25.
- CareEdge Global’s FY26 net worth was Rs 25.1124 crore, versus Rs 26.0663 crore in FY25.
powered by IRIS

State Bank of India has completed a Rs 2.97 crore cash acquisition of a 9.90% stake in CareEdge Global IFSC Limited, purchasing 29,70,000 equity shares at Rs 10 each. SBI disclosed the completed transaction on 16 November 2026, updating its 12 November 2025 announcement of the proposed minority investment.
Know State Bank of India inside out
Results, valuation, peers and who's buying, in one view.
What has SBI acquired in CareEdge Global?
SBI has acquired 29,70,000 equity shares in CareEdge Global, representing a 9.90% holding in the unlisted public limited company. The consideration was Rs 2.97 crore in cash, calculated as the number of acquired shares multiplied by the disclosed purchase price of Rs 10 per share. The filing describes the transaction as an investment for an equity stake and does not state that SBI acquired control.
The material update in the 16 November 2026 disclosure is that the transaction has been completed. SBI had informed the exchanges through its 12 November 2025 letter that it would acquire a stake in CareEdge Global. The latest filing changes the disclosed status from an intended acquisition to a completed purchase after confirming that required regulatory approvals had been obtained.
What business does CareEdge Global operate?
CareEdge Global is a full-service credit rating agency that was incorporated on 29 April 2024. It is an unlisted public limited company with its address in GIFT SEZ, GIFT City, Gandhinagar, Gujarat. SBI identifies the target’s industry as credit rating and does not disclose separate product-level revenue or customer information.
CareEdge Global is the first credit rating agency registered and authorised by the International Financial Services Centres Authority (India), or IFSCA, according to SBI’s filing. That regulatory status is linked to the company’s business as a credit rating agency in the International Financial Services Centre framework. The filing does not identify rating mandates, international operations beyond its Indian address, or a commercial partnership with SBI.
The company’s financial history in the annexure covers FY25 and FY26, consistent with its April 2024 incorporation date. SBI provided turnover and net-worth figures for those two periods, but did not provide profit or loss, debt, cash flow, valuation methodology or the post-transaction total number of shares outstanding.
How did CareEdge Global’s turnover and net worth change?
CareEdge Global’s turnover rose to Rs 9.0029 crore in FY26 from Rs 1.9524 crore in FY25, an increase of Rs 7.0505 crore. Turnover was therefore higher in the later period reported by SBI. The filing does not explain the drivers of the increase or state whether the higher turnover resulted in a profit.
Net worth moved in the opposite direction, falling to Rs 25.1124 crore in FY26 from Rs 26.0663 crore in FY25, a decline of Rs 95.39 lakh. The comparison shows turnover rising between FY25 and FY26 while net worth declined. SBI does not provide a reconciliation of capital, reserves, profit, losses or other factors behind the movement in net worth.
The Rs 2.97 crore purchase consideration equals 29,70,000 shares acquired at Rs 10 each. It should not be treated as a valuation of CareEdge Global because SBI did not disclose an enterprise value, market value, valuation methodology or the basis on which the Rs 10 share price was determined.
Got a follow-up? Ask IRIS
Were approvals obtained and was this a related-party transaction?
The required regulatory approvals were obtained and the acquisition was completed, SBI said in its 16 November 2026 annexure. The filing does not identify individual approvals, approval dates or the regulators that issued them. It confirms only that the approvals required for the Rs 2.97 crore transaction had been secured.
SBI answered “No” to the disclosure question on whether the acquisition was a related-party transaction and whether its promoter, promoter group or group companies had an interest in CareEdge Global. On the information in the filing, the investment is not classified as a related-party transaction. SBI did not disclose the target’s other shareholders or its governance arrangements after the 9.90% purchase.
Cash was the consideration form rather than a share swap or another non-cash structure. SBI stated that the cash amount was computed by multiplying purchased shares by the purchase price per share. At Rs 10 for each of 29,70,000 shares, that mechanism produces the disclosed consideration of Rs 2.97 crore.
What does completion mean for SBI’s disclosed investment?
Completion means SBI now holds the disclosed 9.90% equity interest in CareEdge Global rather than merely having announced an intention to purchase it on 12 November 2025. The 9.90% holding is a minority stake, and the filing does not state that SBI has received board representation, management rights, voting arrangements beyond ordinary equity ownership or operational control.
The disclosed object of the transaction is an investment of Rs 2.97 crore for a 9.90% equity stake. SBI does not state a financial-return target, a timetable for further purchases, an integration plan, a rating-business partnership or a commitment to provide additional capital. The filing therefore establishes the investment’s price, size and completed status, while leaving its longer-term commercial outcomes undisclosed.
Conclusion
The filing confirms that SBI has moved from its 12 November 2025 acquisition announcement to ownership of a 9.90% stake in CareEdge Global for Rs 2.97 crore in cash. The target is a recently incorporated, IFSCA-authorised credit rating agency whose turnover increased from Rs 1.9524 crore in FY25 to Rs 9.0029 crore in FY26, while net worth declined by Rs 95.39 lakh to Rs 25.1124 crore.
What to watch next is whether SBI discloses a further capital commitment, a governance role, a commercial arrangement or a change in its 9.90% holding. The 16 November 2026 filing confirms completion and regulatory approvals, but does not disclose a future investment plan, performance target, board representation or timetable for another transaction.


